...
首页> 外文期刊>Journal of Molecular and Cellular Cardiology >Bovine hereditary cardiomyopathy: an animal model of human dilated cardiomyopathy.
【24h】

Bovine hereditary cardiomyopathy: an animal model of human dilated cardiomyopathy.

机译:牛遗传性心肌病:人类扩张型心肌病的动物模型。

获取原文
获取原文并翻译 | 示例

摘要

Bovine hereditary cardiomyopathy (bCMP) displays clinical characteristics of human idiopathic dilated cardiomyopathy (DCM). We studied isometric force of contraction in right ventricular trabeculae, plasma and tissue catecholamines, beta- and alpha 1-adrenoceptor density, Gi proteins and adenylyl cyclase activity in eight hearts with bCMP and eight control hearts (right and left atria and ventricles each). Results: Compared to control, the potency of isoprenaline in bCMP was eight-fold decreased, whereas the maximal positive inotropic effect of isoprenaline as well as the efficacy and potency of calcium were unchanged. Plasma noradrenaline was increased by 240%. Tissue noradrenaline and adrenaline were decreased by 36-63% and 58-69%, whereas dopamine was increased by 105-218%. beta-adrenoceptor density was drastically reduced by 90%, but binding affinity was unchanged. alpha-Adrenoceptor density and binding affinity were unchanged. Total PTX-substrates were increased in bCMP by 28-99%. Basal adenylyl cyclase activity was decreased by 36-47%. Similarly, stimulation by GTP, GMPPNP, isoprenaline, sodium fluoride, manganese or forskolin was attenuated by 26-62% (atria) and 45-66% (ventricles). In conclusion, we found marked activation of the sympatho-adrenergic system, downregulation of beta-adrenoceptors, upregulation of Gi proteins, global desensitization of adenylyl cyclase and selective subsensitivity to beta-adrenergic inotropic stimulation. These results closely resemble the characteristic alterations in the beta-adrenoceptor-G protein-adenylyl cyclase pathway in human heart failure, indicating that they are general features of heart failure. The similarity to human DCM, the inheritance and the availability of large tissue samples make bCMP a suitable model for human DCM.
机译:牛遗传性心肌病(bCMP)具有人类特发性扩张型心肌病(DCM)的临床特征。我们研究了八名bCMP心脏和八名对照心脏(右,左心房和心室)的右心小梁,血浆和组织儿茶酚胺,β-和α1-肾上腺素受体密度,Gi蛋白和腺苷酸环化酶活性的收缩等距力。结果:与对照组相比,异戊二烯在bCMP中的效力降低了八倍,而异戊二烯的最大正性肌力作用以及钙的效力和效力均未改变。血浆去甲肾上腺素增加了240%。组织去甲肾上腺素和肾上腺素减少了36-63%和58-69%,而多巴胺增加了105-218%。 β肾上腺素受体的密度急剧降低了90%,但结合亲和力没有改变。 α-肾上腺素能受体的密度和结合亲和力没有变化。总的PTX底物的bCMP增加了28-99%。基底腺苷酸环化酶活性降低了36-47%。同样,GTP,GMPPNP,异丙肾上腺素,氟化钠,锰或福司可林的刺激减弱了26-62%(心房)和45-6%(心室)。总之,我们发现交感肾上腺素系统明显激活,β-肾上腺素受体下调,Gi蛋白上调,腺苷酸环化酶的整体脱敏以及对β-肾上腺素性变力刺激的选择性亚敏感性。这些结果非常类似于人心力衰竭中β-肾上腺素受体-G蛋白-腺苷酸环化酶途径的特征性变化,表明它们是心力衰竭的一般特征。与人DCM的相似性,大组织样本的继承和可用性使bCMP成为人DCM的合适模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号